Merck files new termination plan
505343
BOSTON (CBS.MW) -- Merck &amp; Co. has adopted a new plan to compensate senior management in case of a corporate takeover, according to regulatory filings made Monday.
316389
MERCK faces a fresh barrage of lawsuits over its Vioxx arthritis drug that together could cost it as much as $18 billion (Â£9.8 billion) as hundreds of lawyers from across America will next week team up for a combined attack on the embattled drug
446961
This article was reported and written by Alex Berenson, Gardiner Harris, Barry Meier and Andrew Pollack. In May 2000, executives at Merck, the pharmaceutical giant under siege for its
236746
A month after Merck quit selling Vioxx in the face of new evidence that its blockbuster painkiller caused heart attacks, strokes and other serious ailments, the company and plaintiffsâ lawyers are scrambling to adjust to a surge in related lawsuits.
334636
With its stock plunging, the drug giant Merck has adopted a plan that could give its top executives big bonuses if the company is taken over.
600651
Merck, the beleaguered US pharmaceuticals group, could be forced to pay out as much as $18bn (Â£9.7bn) over 10 years as a result of lawsuits linked to Vioxx, its controversial arthritis drug.
173007
The Food and Drug Administration told Merck &amp; Co. that it requires further safety and efficacy data before it will approve its successor drug to now defunct pain reliever Vioxx, the pharmaceutical maker announced Friday.
375780
Merck &amp; Co. said it&#39;s withdrawing its Vioxx painkiller, which generated $2.5 billion in worldwide sales last year, because of data showing an increased risk of heart attack and stroke.
659314
A Brooklyn lawyer announced plans yesterday to file the first federal lawsuits against Merck &amp; Co. on behalf of New Yorkers who developed heart troubles using the arthritis drug Vioxx.
102650
Drugs giant Merck & Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs' lawyers, the New York Times reported on Friday.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
465386
An experimental HIV drug from Merck &amp; Co. Inc. should be quickly approved for use by patients running out of treatment options, federal advisers recommended Wednesday.
140168
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market because it increases the risk of heart attack and stroke, a move that sent the company&#39;s
298813
Merck &amp; Co.'s decision to pull its widely prescribed drug Vioxx off the shelves yesterday because of a risk of stroke and heart attacks marked a new low for a pharmaceutical company that has suffered a steady decline in both market position and prestige over the last decade.
307128
Drugmaker Merck acknowledged Monday that it has hired an executive search firm to look for a successor to Chairman and CEO Raymond Gilmartin, but said it did so before its decision
179055
Drugmaker Merck has set up an independent committee to review the firm&#39;s actions prior to the withdrawal of its painkiller Vioxx from the market in September.